Every 7 minutes, a woman dies from postpartum hemorrhage.
At Nataly, we are developing an innovative medical device to detect postpartum hemorrhage in real time — saving lives through early intervention.
Postpartum Hemorrhage
Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide.
Every year, 14 million women experience excessive bleeding after childbirth, and 70,000 of them do not survive.
-
Current methods to measure blood loss are inaccurate and unreliable, leading to delayed treatment, preventable deaths, and increased healthcare costs. The lack of precise quantification means that many cases go unnoticed until it’s too late.
-
Blood loss after childbirth is visually estimated, a method prone to serious errors. Midwives often underestimate the amount of blood loss, leading to delayed detection of PPH. Since symptoms can be masked in the early stages, life-threatening hemorrhages are often identified too late.
-
PPH can escalate rapidly. By the time visible symptoms appear — such as low blood pressure or dizziness — the blood loss is already critical. Delayed intervention increases the risk of severe complications, emergency surgeries, and death. Additionally, mismanagement of PPH results in unnecessary blood transfusions, prolonged hospital stays, and higher healthcare costs.
Our Vision & Mission
At Nataly, we are pioneering a postpartum pad that not only absorbs blood but also measures blood loss in real time.
This enables early detection of hemorrhage, allowing for immediate medical intervention — reducing healthcare costs, preventing severe complications, and most importantly, saving lives.